Semaglutide has documented ocular risks, including rare vision-threatening NAION.
Claim:
GLP-1 receptor agonist treatment has numerous side effects, including adverse effects on eyesight.
HARDLY BS
Topic
GLP-1 receptor agonists
2 claims checked
Clinical evidence shows GLP-1 agonists’ cardiovascular and metabolic benefits usually outweigh side effects.
Claim:
GLP-1 receptor agonists produce net positive health outcomes that may exceed the negative side effects commonly highlighted in media coverage.
HARDLY BS